Buprenorphine Tablet
Product Images NDC 67296-2173

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 67296-2173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine-figure (Buprenorphine Figure)

FDA Label Image

Buprenorphine-label-2mg (Buprenorphine Label 2mg)

This text appears to be providing information about a specific medication, Buprenorphine Sublingual Tablets. It includes details such as NDC number, dosage, usage instructions, storage guidelines, and precautions. It also mentions the importance of dispensing the medication with a Medication Guide and protecting it from light. Additionally, it refers to the manufacturer and offers a link to access the Medication Guide online.*

FDA Label Image

Buprenorphine-label-8mg (Buprenorphine Label 8mg)

This text contains information about Buprenorphine Sublingual Tablets, including dosage instructions, storage conditions, and safety precautions. It advises pharmacists to dispense the medication with a Medication Guide to each patient and warns about the need for emergency medical care if children accidentally ingest the tablets. The text also provides details on the composition of the tablets and the manufacturer's information. For more information, a Medication Guide is available at the provided website.*

FDA Label Image

Buprenorphine-str (Buprenorphine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.